Axcelis Technologies (NASDAQ:ACLS) Issues Quarterly Earnings Results

Axcelis Technologies (NASDAQ:ACLS) announced its earnings results on Monday. The semiconductor company reported $1.54 earnings per share for the quarter, beating analysts’ consensus estimates of $1.25 by $0.29, Zacks reports. Axcelis Technologies had a return on equity of 24.16% and a net margin of 20.65%. Axcelis Technologies updated its Q1 2025 guidance to 0.380-0.380 EPS.

Axcelis Technologies Price Performance

Axcelis Technologies stock opened at $59.30 on Wednesday. The firm has a market cap of $1.93 billion, a PE ratio of 8.77, a price-to-earnings-growth ratio of 2.39 and a beta of 1.52. Axcelis Technologies has a one year low of $57.68 and a one year high of $158.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. The stock’s fifty day moving average price is $71.28 and its two-hundred day moving average price is $88.45.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Craig Hallum lowered their price objective on shares of Axcelis Technologies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, January 15th. Finally, Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $154.00.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.